Topical Calcineurin Inhibitors: Expanding Indications for Corneal and Ocular Surface Inflammation


This is an Editorial and does not have an abstract.



1. Lee YJ, Kim SW, Seo KY. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases. Am J Ophthalmol 2013;155:804–813.

2. Miyazaki D, Tominaga T, Kakimaru-Hasegawa A, Nagata Y, Hasegawa J, Inoue Y, et al. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases. Ophthalmology 2008;115:988–992.

3. Ghaffari R, Ghassemi H, Zarei-Ghanavati M, Latifi G, Dehghani S, Haq Z, et al. Tacrolimus eye drops as adjunct therapy in severe corneal endothelial rejection refractory to corticosteroids. Cornea 2017;36:1195–1199.

4. Hashemian MN, Latifi G, Ghaffari R, Ghassemi H, Zarei- Ghanavati M, Mohammadi SF, et al. Topical tacrolimus as adjuvant therapy to corticosteroids in acute endothelial graft rejection after penetrating keratoplasty: a randomized controlled trial. Cornea 2018;37:307–312.

5. Kheirkhah A, Zavareh M, Farzbod F, Mahbod M, Behrouz MJ. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis. Eye (Lond) 2011;25:872–880.

6. Akbari A, Soltani Moghadam R, Elmi R, Nosrati A, Taghiabadi E, Aghdami, N. Topical Tacrolimus as an adjunct to conventional therapy for herpetic stromal keratitis: a randomized clinical trial. J Ophthalmic Vis Res 2019;14.

7. Chatterjee A, Bandyopadhyay S, Bandyopadhyay SK. Efficacy, safety, and steroid sparing effect of topical cyclosporine a 0.05% in vernal keratoconjunctivitis in Indian children. J Ophthalmic Vis Res 2019;14.